NLS Pharmaceutics Ltd (NLSP)
1.920
-0.46
(-19.33%)
USD |
NASDAQ |
Dec 20, 16:00
1.95
+0.03
(+1.57%)
After-Hours: 20:00
NLS Pharmaceutics Total Assets (Quarterly): 1.194M for June 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 290.33M |
| CRISPR Therapeutics AG | 2.256B |
| Addex Therapeutics Ltd | 14.46M |
| Molecular Partners AG | 183.31M |
| MoonLake Immunotherapeutics | 518.21M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.46M |
| Shareholders Equity (Quarterly) | -9.268M |